World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000030626
Date of registration: 28/12/2017
Prospective Registration: No
Primary sponsor: Hamamatsu University School of Medicine
Public title: Investigation on the effectiveness of histidine copper treatment of Menkes disease patients
Scientific title: Investigation on the effectiveness of histidine copper treatment of Menkes disease patients - Investigation on the effectiveness of histidine copper treatment of Menkes disease patients
Date of first enrolment: 2014/11/28
Target sample size: 2
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034969
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Tokiko Fukuda
Address:  1-20-1 Hamdayama,Higashi-ku,Hamamatsu-city,Shizuoka Japan
Telephone: 053-435-2638
Email: toki-fkd@hama-med.ac.jp
Affiliation:  Hamamatsu University School of Medicine Department of Pediatrics
Name:     Tokiko Fukuda
Address:  1-20-1 Hamdayama,Higashi-ku,Hamamatsu-city,Shizuoka Japan
Telephone: 053-435-2638
Email: toki-fkd@hama-med.ac.jp
Affiliation:  Hamamatsu University School of Medicine Department of Pediatrics
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: None

Age minimum: Not applicable
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Menkes disease
Intervention(s)
Weekly,subcutaneous injection of histidine copper (750microgram once) is performed three times per week.It is continued every week until the end of the research during the research period.
Primary Outcome(s)
development
Secondary Outcome(s)
The presence or absence of spasm
Secondary ID(s)
Source(s) of Monetary Support
Self funding
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available: Yes
Date Posted:
Date Completed: 31/03/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history